newsfilter
← Latest News
GlobeNewswire·

PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET

  • PetVivo Holdings, Inc. will host a conference call on Friday, August 14, 2026, at 5:00 p.m. Eastern time to discuss fiscal first quarter results ended June 30, 2026.
  • Financial results will be released via press release prior to the call, followed by a management presentation & question-and-answer period.
  • Call details include dial-in number +1 669 444 9171, Meeting ID 85778580447, passcode 067744, with live webcast & replay available via the company website link.
  • PetVivo is an emerging biomedical company focusing on manufacturing, commercialization, & licensing of medical devices for equine & companion animals by leveraging human therapies.
  • The company holds a portfolio of twelve patents & six trade secrets protecting its biomaterials, products, processes, & methods.
  • Lead product SPRYNG® with OsteoCushion® technology is a veterinarian-administered injection for managing lameness & joint afflictions in cats, dogs, & horses, currently available for commercial sale.
  • CEO John Lai is the primary contact for the company via email or phone at (952) 405-6216.
  • The announcement includes standard forward-looking statements disclaiming guarantees of future performance & referencing risks detailed in the 2026 Form 10-K.